The challenges and promises of new therapies for cystic fibrosis.
about
Pseudomonas aeruginosa in premise plumbing of large buildingsCorrection of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis miceHuman pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling.Mitochondrial DAMPs induce endotoxin tolerance in human monocytes: an observation in patients with myocardial infarction.Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences.Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissuesPharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Nanotechnology approaches for inhalation treatment of fibrosis.Sustained interleukin-1β exposure modulates multiple steps in glucocorticoid receptor signaling, promoting split-resistance to the transactivation of prominent anti-inflammatory genes by glucocorticoidsThe spatial profiles and metabolic capabilities of microbial populations impact the growth of antibiotic-resistant mutantsTargeting cytosolic proliferating cell nuclear antigen in neutrophil-dominated inflammation.Apoptotic process in cystic fibrosis cells.Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction.Epitope mapping of monoclonal antibodies using synthetic oligosaccharides uncovers novel aspects of immune recognition of the Psl exopolysaccharide of Pseudomonas aeruginosa.Host-Pathogen Interface: Progress in Understanding the Pathogenesis of Infection Due to Multidrug-Resistant Bacteria in the Intensive Care Unit.Understanding the biomimetic properties of gallium in Pseudomonas aeruginosa: an XAS and XPS study.Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines.Tobramycin and bicarbonate synergise to kill planktonic Pseudomonas aeruginosa, but antagonise to promote biofilm survival.Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis.Influenza A matrix protein M2 downregulates CFTR: inhibition of chloride transport by a proton channel of the viral envelope.Development of an airway mucus defect in the cystic fibrosis rat.Gender differences in bronchiectasis: a real issue?DNA Sliding Clamps as Therapeutic TargetsHost Defence against Bacterial Biofilms: “Mission Impossible”?Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
P2860
Q26746248-C8E4AC9A-1F99-4E32-AC78-B0C3688EA02FQ27303954-EA3AF99E-4813-4E28-ACA0-27221693ECA6Q30313776-89A4C837-DDBB-4630-8278-3E4B39DB8F7AQ33567624-0A3AD8E3-318B-474C-B6A0-CB478BFA323AQ33762394-23762821-6C87-4790-B574-1D2D9788A273Q33897664-B82E1DD7-511D-45E7-8967-C1E8B919B708Q34290997-DE3AC3C7-7DF7-4594-8B05-B230DD02DC2EQ34297656-36CAA81D-4BA3-45CC-8190-3B5CEE1A71B8Q34449624-4C9412BD-EBF1-4CDF-8371-4173F7D062F6Q35573505-FED6EAF9-C8E8-4D94-8541-80024D36E420Q36111334-5D07E690-6E82-4810-9A93-25E9EF30DE38Q38062530-552F4D75-051E-4DB7-AB52-2ECB7A2878FBQ38116437-D87716A0-1A40-48EC-9579-734E4C8D18A6Q38138015-D556F4BA-9874-4157-9BB4-492B79A84F6DQ38311099-482F6B9D-E07E-457B-A792-4A96523445D1Q38735259-C05C9F58-3B5E-47D5-8D34-74774933D6A8Q38775255-0FF70249-2FAB-4AE4-ADE5-17281F122084Q39488014-4E10ECB3-EF58-4F98-8FD7-179F97040400Q40663341-755EA2A5-C5AD-4BB7-8DA2-78ED448D5A98Q41302801-94C0CD4B-E279-4A2A-8859-FC7725D6AA7EQ46149823-2AB692F6-2E70-474D-9DFC-7654E670F971Q47722821-32A5D342-1471-4CF2-A46B-84D0E0E7DE6CQ55299552-6FD9FB14-BCDB-46C2-A504-24F4FB63C5CBQ58580556-DC08BD21-C6EC-4184-B13C-63BF9039798CQ58692848-44B0B14C-161A-478E-90B1-C49A97982A5AQ59133957-6878E18D-6273-44D2-B29A-0FAC01D02807
P2860
The challenges and promises of new therapies for cystic fibrosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The challenges and promises of new therapies for cystic fibrosis.
@en
type
label
The challenges and promises of new therapies for cystic fibrosis.
@en
prefLabel
The challenges and promises of new therapies for cystic fibrosis.
@en
P2860
P356
P1476
The challenges and promises of new therapies for cystic fibrosis.
@en
P2093
Gerald B Pier
P2860
P304
P356
10.1084/JEM.20121248
P407
P577
2012-07-01T00:00:00Z
2012-07-02T00:00:00Z